Navigation Links
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
Date:7/29/2010

54,000 8,324,774 54,000 ------------------------------------------------------------------------- (Decrease) increase in cash and cash equivalents during the period (4,352,633) 4,616,871 (9,289,461) Impact of foreign exchange on cash and cash equivalents 415,280 - 46,483 ------------------------------------------------------------------------- Cash and cash equivalents, beginning of the period 27,143,314 7,366,481 32,448,939 ------------------------------------------------------------------------- Cash and cash equivalents, end of the period 23,205,961 11,983,352 23,205,961 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Cumulative from inception Six Month on April 2, Period 1998 to Ending June June 30, 30, 2009 2010 $ $ ----------------------------------------------------------- OPERATING ACTIVITIES Net loss for the period (8,292,403) (127,281,185) Deduct non-cash items Amortization - intellectual property 180,750 3,615,000 Amortization - property and equipment 33,840 591,587 Stock based compensation 20,181 5,195,545 Other non-cash items - 1,447,854 Net changes in non-cash working capital (1
'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
2. Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
4. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
5. Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
6. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
7. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
8. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
9. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
10. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
11. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 Carahsoft and ... Thursday, January 23, 2014 at 2pm EST (11am PST), ... The topic focuses on how technology can turn raw, ... decisions for government agencies. The online webinar will last ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... 14, 2014 In recent years, growing ... methods in product development and promotion has led to ... mistrust, fueled by concerns about the insidious impact of ... of spectacular fines to the world’s biggest pharmas for ...
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
Breaking Biology Technology:Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... Texas, March 28, 2012   Luminex Corporation ... Dr. Amy Altman, vice president of Biodefense will ... Conference , taking place March 27-29, 2012 in Denver, Colorado. ... of Defense,s Joint Program Executive Office for ...
... SAN DIEGO, March 28, 2012 OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat solid ... to institutional investors of an aggregate of 31,000,000 shares ... a registered public offering.  Additionally, investors received Warrants to ...
... cloaking, a team of French researchers has proposed isolating or ... which the researchers describe in the Optical Society,s ( OSA ... into some of the same principles as optical cloaking and ... and, on an even larger scale, might someday prove useful ...
Cached Biology Technology:Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 2Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 3Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference 4OncoSec Closes $7.75 Million Public Offering 2OncoSec Closes $7.75 Million Public Offering 3Not your average heat shield 2
(Date:4/17/2014)... A Kansas State University engineer has developed a ... detects improvised explosive devices. The same technique could ... the Steven M. and Kay L. Theede chair ... nuclear engineering, and his research team have created ... or in car trunks. The distance detection method ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
(Date:4/17/2014)... Ongoing deforestation and fragmentation of forests in the ... remnant forests, contributing to rapid and widespread forest ... of researchers., The findings show that forests in ... severe droughts coupled with forest fires lead to ... said Jennifer Balch, assistant professor of geography, Penn ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2White House honors Clemson professor as 'Champion of Change' for solar deployment 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3
... time to stop thinking of solar energy as a boutique ... generates about 1 percent of the electricity in the US. ... an associate professor of electrical engineering and materials science at ... to go mainstream. It,s a matter of economics. A ...
... WEST LAFAYETTE, Ind. - Wheat,s genetic resistance to Hessian flies ... U.S. Department of Agriculture scientists believe that other plants may ... Purdue and USDA research team developed a method to test ... simulates the effect of a transgenic plant without the lengthy ...
... team at Worcester Polytechnic Institute (WPI) has received a ... develop a smart phone application that will help people ... disease. The four-year project will be organized through WPI,s ... wound care specialists at the University of Massachusetts Medical ...
Cached Biology News:Affordable solar? 2Wheat can't stop Hessian flies, so scientists find reinforcements 2WPI receives $1.2 million to develop smart phone app for advanced diabetes and wound care 2WPI receives $1.2 million to develop smart phone app for advanced diabetes and wound care 3WPI receives $1.2 million to develop smart phone app for advanced diabetes and wound care 4
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
...
Biology Products: